SCHEMBL26107697

SCHEMBL26107697

O=C1c2ccccc2C(=O)N1c1n[nH]c2c(Br)cc(Cl)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALPL P05186 6/20 0.40
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ APEX1 P27695 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ PTK2B Q14289 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30612161 1.00 ALPL (0.40) ALPLHTTKMT2AMEN1ALDH1A1
SCHEMBL20552092 0.74 ALPL (0.39) ALPLHTTKMT2AMEN1ALDH1A1
SCHEMBL15995723 0.71 TP53 (0.42) ALPLHTTKMT2AALDH1A1MAPK1
SCHEMBL30881780 0.71 TP53 (0.42) ALPLHTTKMT2AALDH1A1MAPK1
SCHEMBL30611994 0.70 ALDH1A1 (0.33) HTTKMT2AMEN1ALDH1A1CYP3A4
SCHEMBL26106122 0.70 ALDH1A1 (0.33) HTTKMT2AMEN1ALDH1A1CYP3A4
SCHEMBL30367456 0.69 ALPL (0.40) ALPLKMT2AMEN1ALDH1A1CYP3A4
SCHEMBL30612152 0.68 ALDH1A1 (0.32) HTTKMT2AMEN1ALDH1A1CYP3A4
SCHEMBL26107180 0.68 ALDH1A1 (0.32) HTTKMT2AMEN1ALDH1A1CYP3A4
SCHEMBL25239396 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499629-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2025-02-05 — — EP disclosed
WO-2023183919-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) 2023-09-28 — — WO disclosed
Send feedback